← FDA Drug Approvals (Drugs@FDA)
OTICAIR
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BAUSCH AND LOMB · Approved 1996-08-28
Drug application
- FDA Application #
ANDA064065- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OTICAIR
- Generic name
- NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE
- Active ingredients
- HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
- Dosage form
- SUSPENSION/DROPS
- Route
- OTIC
- Marketing status
- Prescription
- Sponsor
- BAUSCH AND LOMB
- Manufacturer
- Bausch & Lomb Incorporated
- First approval
- 1996-08-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown